Advances in Receptor Agonists
An agonist is a chemical that activates a receptor to produce a biological response. Receptors are cellular proteins whose activation causes the cell to modify what it is currently doing. In contrast, an antagonist blocks the action of the agonist, while an inverse agonist causes an action opposite to that of the agonist. Receptors can be activated by either endogenous agonists (such as hormones and neurotransmitters) or exogenous agonists (such as drugs), resulting in a biological response. A physiological agonist is a substance that creates the same bodily responses but does not bind to the same receptor.
In the present book, ten typical literatures about receptor agonists published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on receptor agonists. We hope this book can demonstrate advances in receptor agonists as well as give references to the researchers, students and other related people.
Sample Chapter(s)
Preface (174 KB)
Components of the Book:
  • Chapter 1
    Human bitter taste receptors undergo internalization in an agonist-selective fashion
  • Chapter 2
    Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits
  • Chapter 3
    Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I Insights into Activation Molecular Mechanism
  • Chapter 4
    National Utilization and Expenditure Trends of GLP-1 Receptor Agonists and Dual GLP-1GIP Agonist in Croatia, 2017–2024
  • Chapter 5
    Nutrition Considerations in Youth with Type 2 Diabetes using GLP-1 Receptor Agonists: A Commentary
  • Chapter 6
    Dynamics of the PAC1 receptor in apo, peptide agonist-bound, and G protein complexed states
  • Chapter 7
    Stereoselective Synthesis and Biological Evaluation of Perhydroquinoxaline-Based κ Receptor Agonists
  • Chapter 8
    Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
  • Chapter 9
    Tuning insulin receptor signaling using de novo-designed agonists
  • Chapter 10
    Stimulator of Interferon Genes Ablation in T Cells Is Required for the Efficacy of Stimulator of Interferon Genes Agonists in Chimeric Antigen Receptor-T Cell Immunotherapy of Pancreatic Cancer
Readership: Students, academics, teachers and other people attending or interested in receptor agonists.
Matthias H Tschöp MD
Division of Metabolic Diseases, Technische Universität München, Helmholtz Diabetes Center, Helmholtz Zentrum München, Munich, Germany

Nikolay N. Kuzmich
The Maurice and Vivienne Wohl Institute for Drug Discovery, Weizmann Institute of Science, Rehovot 7610001, Israel

Mate Car
Department of Primary Care & Public Health, Imperial College London, London SW7 2AZ, UK; Centre for Data-Driven Policy and Management, Catholic University of Croatia, 10000 Zagreb, Croatia; School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia

and more...
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top